Clinical Trials Logo

18F-FDG PET clinical trials

View clinical trials related to 18F-FDG PET.

Filter by:
  • None
  • Page 1

NCT ID: NCT01927939 Recruiting - Breast Cancer Clinical Trials

18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.

Start date: October 2012
Phase: N/A
Study type: Observational

This study is to evaluate the effectiveness of 18F-FDG PET in following up of metastastic bone lesions and in predicting outcome for breast cancer patients after therapy. Primary outcome: Using 18F-FDG uptake to evaluate the metastatic bone status after treatment. The PET results will be compared with the results in Tc-99m MDP bone scintigraphy. Secondary outcome: Evaluate the relationship between the 18F-FDG uptake of the metastatic bone lesions and (1) breast cancer related tumor marker, (2) patients' survival.